Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$19.0 million.

  • Phibro Animal Health's Cash from Financing Activities fell 10686.88% to -$19.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$42.6 million, marking a year-over-year decrease of 11680.06%. This contributed to the annual value of $207.1 million for FY2025, which is 316049.05% up from last year.
  • As of Q4 2025, Phibro Animal Health's Cash from Financing Activities stood at -$19.0 million, which was down 10686.88% from $16.3 million recorded in Q3 2025.
  • Phibro Animal Health's Cash from Financing Activities' 5-year high stood at $276.3 million during Q4 2024, with a 5-year trough of -$32.2 million in Q1 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was $1.5 million (2023), whereas its average is $11.7 million.
  • Examining YoY changes over the last 5 years, Phibro Animal Health's Cash from Financing Activities showed a top increase of 197908.87% in 2024 and a maximum decrease of 235285.49% in 2024.
  • Quarter analysis of 5 years shows Phibro Animal Health's Cash from Financing Activities stood at -$14.6 million in 2021, then skyrocketed by 125.49% to $3.7 million in 2022, then plummeted by 495.72% to -$14.7 million in 2023, then skyrocketed by 1979.09% to $276.3 million in 2024, then plummeted by 106.87% to -$19.0 million in 2025.
  • Its Cash from Financing Activities stands at -$19.0 million for Q4 2025, versus $16.3 million for Q3 2025 and -$7.8 million for Q2 2025.